The prospect of tapping growing demand for dairy in markets in Asia has driven another deal in Europe's dairy sector - this time a merger be...
The Chinese New Year is marked on Monday (23 January) but the same old questions over the safety of food made in the country have reared the...
just-food's latest category crunch looks at the infant formula sector in China, an industry often rocked in the last decade by concerns over product safety but one that domestic and international manufacturers believe has the potential for rapid growth. Petah Marian reports.
In part two of just-food's category crunch on China's infant formula sector, Petah Marian reports on how product development has reacted to the fears over product safety.
Concerns over the grain crisis in Russia trickled down through the financial results this week, with companies like Nestle and Sara Lee hinting at possible price increases due to increased commodity prices.
Infant formula is a growing industry in China but, in recent years, it has not been without its problems. The 2008 melamine scandal, in which contaminated milk powder killed and sickened thousands of babies, rocked the sector - and damaged the reputation of some of the country's largest players. But, despite the promise of tougher regulation, the sector has still seen isolated incidents this year.
Chinese infant formula maker Synutra has confirmed it has entered into a definitive merger agreement for a "going private transaction".
Synutra, the Chinese, US-listed infant formula producer, has lowered its forecast for annual profits amid a delay to a project in France, weak global raw-milk prices and the impact of exchange rates.
Synutra International, the Chinese infant formula producer, has forecast a rise in annual profits in its new financial year after seeing earnings slide in the year to the end of March.
Sodiaal, the French dairy co-operative, is to manufacture UHT milk to be sold in China under the local brands of infant formula group Synutra.
Chinese infant formula manufacturer Synutra has announced plans to invest in building a UHT plant at its site in the French town of Carhaix.
Chinese infant formula maker Synutra has received a preliminary proposal from chairman and CEO Liang Zhang to take the company private by acquiring all outstanding stock for US$5.91 a share.
Synutra, the US-listed Chinese infant formula producer, has warned its revenue and net income forecasts will be "difficult to achieve" due to lower sales in its core business, foreign exchange losses and promotional costs.
Russia this week reportedly ruled out the use of GMOs in its food production, a further stiffening of its position on the issue. In the US, meanwhile, the Obama administration announced plans to halve food waste in 15 years. And, among a series of stories out of France, came news of raids from the country's competition watchdog on compote manufacturers.
Les Maîtres Laitiers du Cotentin (MLC) has signed a contract to supply Chinese infant formula firm Synutra International that will see the French dairy build a production plant in Normandy.
This week's results included an upbeat US snack group Snyder's-Lance reporting higher second-quarter sales and profits, improved half-year revenue and earnings at seafood giant Thai Union and declines at an acquisitive SunOpta.
Challenging conditions in the global dairy sector were again confirmed when both First Milk and DMK reported lower earnings. European meat firm Vion, however, insisted that its results were "improved" on 2014 despite racking up losses in the period. Here are the results in brief for this week.
Chinese infant formula maker Synutra International booked an increase in earnings during the first nine months of its financial year, driven by sales gains and improved efficiency.
Synutra International, the Chinese infant formula manufacturer, has raised its full-year outlook having registered an increase in income from operations of more than 50% in the first half of the year.
Chinese infant formula group Synutra has raised its full-year earnings forecast after witnessing sales growth of "at least" 50% in the second quarter.
Chinese infant formula manufacturer Synutra has reported a jump in first-quarter profits, helped by higher selling prices and boosted by proceeds from a plant disposal.
Chinese infant nutrition firm Synutra International has been able to capitalise on the Beijing's production licence initiative, picking up distribution where other companies fail to gain a permit to manufacture.
Chinese infant formula company Synutra International attributed sequential growth in shipment volumes to increased marketing efforts.
Chinese infant formula firm Synutra International has reported "strong" quarterly results, with sales and earnings better than it expected.
Chinese infant formula firm Synutra International has started construction of a drying facility for powdered milk and fat-enriched demineralised whey in Carhaix in France.
Chinese infant formula group Synutra International has moved to a profit in the first half of its financial year.
Chinese infant formula group Synutra International said it was "pleased" with the performance and ongoing recovery of its core business as it booked an increase in first-quarter earnings and sales.
Chinese infant formula firm Synutra International has insisted it has seen its core business return to profitability in the fourth quarter at the end of a year which saw sales fall and losses widen.
Chinese infant formula group Synutra International has again cut its full-year financial forecasts after reporting a loss in the third quarter of its fiscal year.
Chinese infant formula group Synutra International has appointed Ning Cai as its CFO.
- 2017: three major drivers of M&A strategy
- The food market in 2017 - consumer trends and M&A
- just-food 2017 Survey - your thoughts on growth
- Food market in 2017: need-to-know US trends
- 2017 - what will shape the UK food sector?
- Premier Foods issues profit warning
- UK's Bakkavor plays down IPO "speculation"
- Kellogg to slash 250 jobs
- Mondelez sells Vegemite to Bega
- Nestle mum on Mead Johnson takeover talk